SPY$769.66▲ +0.6%QQQ$721.25▲ +1.3%DIA$524.68▲ +0.3%IWM$281.29▲ +0.4%AAPL$347.10▲ +0.9%MSFT$531.33▼ -0.2%GOOGL$320.58▲ +1.2%AMZN$253.10▲ +1.6%NVDA$217.94▲ +0.9%META$620.19▼ -1.6%TSLA$407.46▲ +4.0%NFLX$62.52▼ -2.2%AMD$560.26▲ +5.5%AVGO$342.33▲ +4.0%PLTR$198.73▼ -0.1%CRM$240.89▼ -2.7%ORCL$130.53▲ +3.5%JPM$335.79▲ +0.5%V$401.86▼ -0.6%MA$609.85▼ -0.6%BAC$50.68▲ +0.3%WMT$119.32▼ -0.8%COST$992.13▼ -1.3%HD$318.50▼ -0.3%XOM$179.91▼ -2.5%CVX$228.23▼ -1.6%JNJ$268.73▲ +0.9%UNH$410.39▼ -0.1%LLY$1,281.91▲ +0.2%DIS$110.23▼ -0.1%BA$168.18▼ -10.7%COIN$161.09▲ +0.9%MSTR$141.40▲ +1.1%HOOD$94.56▲ +1.9%SOFI$16.40▲ +13.4%TSM$436.87▲ +3.0%BTC$81,242.55▲ +0.5%ETH$2,359.27▲ +0.5% SPY$769.66▲ +0.6%QQQ$721.25▲ +1.3%DIA$524.68▲ +0.3%IWM$281.29▲ +0.4%AAPL$347.10▲ +0.9%MSFT$531.33▼ -0.2%GOOGL$320.58▲ +1.2%AMZN$253.10▲ +1.6%NVDA$217.94▲ +0.9%META$620.19▼ -1.6%TSLA$407.46▲ +4.0%NFLX$62.52▼ -2.2%AMD$560.26▲ +5.5%AVGO$342.33▲ +4.0%PLTR$198.73▼ -0.1%CRM$240.89▼ -2.7%ORCL$130.53▲ +3.5%JPM$335.79▲ +0.5%V$401.86▼ -0.6%MA$609.85▼ -0.6%BAC$50.68▲ +0.3%WMT$119.32▼ -0.8%COST$992.13▼ -1.3%HD$318.50▼ -0.3%XOM$179.91▼ -2.5%CVX$228.23▼ -1.6%JNJ$268.73▲ +0.9%UNH$410.39▼ -0.1%LLY$1,281.91▲ +0.2%DIS$110.23▼ -0.1%BA$168.18▼ -10.7%COIN$161.09▲ +0.9%MSTR$141.40▲ +1.1%HOOD$94.56▲ +1.9%SOFI$16.40▲ +13.4%TSM$436.87▲ +3.0%BTC$81,242.55▲ +0.5%ETH$2,359.27▲ +0.5%
Calls › MCD › Oct 9, 2026
MCD Lean bullish McDonald's Corporation · Consumer Cyclical

Cheap, but not yet cleared.

Published Oct 9, 2026 · Horizon 3-6 months, anchored to the Oct 22… Audited · corrected once
Edge5/10
Evidence7/10
Entry (close)
$236.90 2026-10-08
Since publish
+5.3% to 2026-10-27
vs SPY
+5.9%
3-month verdict
Closes 2027-01-07

Thesis

MCD has de-rated ~35pts vs SPY over one year on a stacking of moderate disappointments — Q2 US comps miss (+0.8% vs +1.06% expected), a surprise $8.5B franchisee-support commitment, and GLP-1 narrative drag — while the consolidated P&L kept growing and the forward multiple compressed to ~17x, the lowest in at least a decade. If FY2026/FY2027 EPS estimates ($12.89/$13.77) stabilize after the Q3 print, the downside is cushioned by the multiple and the upside is a re-rating toward the low-20s on a franchise model expected to compound EPS ~7-8%/yr per consensus with credible unit growth. The bear case that would break this is not traffic softness per se but evidence that the $8.5B signals a structural shift in franchisor/franchisee economics that forces sustained estimate cuts.

Bull case

~17x forward on a franchise model that grew EPS 4.9% in FY2025 with consensus implying ~8% growth in FY2026 ($12.89 vs $11.95), holds a 46% operating margin, is adding ~10,000 net units by 2027, and has 220M loyalty users (+13%). The de-rating is ~35pts vs SPY on events whose cash impact is either modest (comps miss of ~0.3pts), decade-spread and already embedded in guidance (the $8.5B), or contradicted by available data (GLP-1). Peers holding up far better prove the sector multiple isn't broken, so a US value-execution stabilization at Q3 — which Q4 2025's beat showed is achievable — plus continued buybacks could drive a re-rating toward the low-20s multiple, implying 25-40% upside on FY2027 EPS of ~$13.77 with limited fundamental downside given the defensive demand base.

Bear case

Management itself guided to flat industry traffic and admitted value execution failed — twice in three quarters (Q1 warning, Q2 miss) after Q4 2025's win, so momentum is negative, not stable. The $8.5B rent relief is an implicit admission that franchisee economics broke at current rent/royalty loads, and a model whose health depends on franchisee P&Ls is now subsidizing them while corporate targets 50%+ margins — a value-chain split that may force more support or slower royalty growth than consensus models. Revisions are running 11-13 down vs 2 up into the print, and if Q3 misses on comps again, $12.89 FY26 and $13.77 FY27 come down, meaning today's 17x is really 18-19x on realistic numbers with a negative revisions cycle just starting — the classic value-trap setup, as CMG's parallel -20% shows consumer weakness isn't purely an execution excuse.

What would change our mind

  • FY2027 consensus EPS falls materially below ~$13.30 (i.e., >3-4% cut) after the Q3 print — that converts the drawdown from multiple compression into earnings deterioration
  • Q3 US comps negative with management guiding to further franchisee support beyond the announced $8.5B
  • Credible quantified evidence emerges that GLP-1 adoption is reducing QSR traffic/basket size at scale
  • Franchisee-level data (unit economics, closures, transfer values) show systemic distress despite the support package
  • Stock de-rates below ~15x forward with estimates intact — at that point the market is signaling information the public evidence bundle doesn't contain
MCD's 1-year de-rating vs SPY
MCD's 1-year de-rating vs SPY. MCD has lagged SPY by roughly 35 points over the past year, supporting the thesis that sentiment and multiple compression—not earnings collapse—drove the drawdown.

Since publication vs SPY · closed horizons are frozen

1 weekfinal
+2.9%
+2.4% raw · hit
1 monthrunning
+5.9%
+5.3% raw
3 monthsrunning
+5.9%
+5.3% raw
6 monthsrunning
+5.9%
+5.3% raw

The full research everything the view rests on

Direct answer to the question asked
MCD's ~20% one-year drawdown is overwhelmingly multiple compression, not earnings deterioration: FY2025 EPS grew 4.9% to $11.95 with a record 46.1% operating margin, yet the stock trades at ~17x forward — a decade-low multiple. The bear case is real but specific: US comps decelerating, management itself guiding to flat industry traffic, and estimate revisions running 11-down/2-up into the Oct 22 Q3 print. At this price the risk/reward skews modestly positive for a 3-6 month holder willing to underwrite one more earnings test, but the negative revision momentum argues for waiting for the print rather than pre-committing.
Where the edge would come from

What the price assumes

At ~17x forward FY2026 EPS, the market is pricing MCD as an ex-growth staple facing sustained estimate cuts — implying either that consensus $12.89/$13.77 is too high, or that the durable ~20x+ premium the market historically paid for the franchise model is permanently impaired by strained franchisee economics, flat industry traffic, and GLP-1 demand risk. Peers (YUM -2.5% 1y, QSR +5.1% 1y) trading far better indicates the market sees this as MCD-specific execution failure, not a sector de-rating.

Why the market may be wrong

The selloff's magnitude is inconsistent with the measured fundamental damage: FY2025 revenue +3.7%, EPS +4.9%, record operating margin; and Q2 2026 systemwide sales +5% with loyalty users +13% to ~220M. The two biggest narrative drivers look overstated on the evidence: the $8.5B franchisee support is spread over a decade (~$5B by 2030) and is already embedded in the company's own mid-to-high-80s% FCF conversion and low-to-mid-50s% margin targets for 2030; and the GLP-1 demand-collapse story is contradicted by the available industry data (a 2026 National Restaurant Association survey found GLP-1 users buy restaurant food MORE often, 7.6 vs 5.1x/week, with mix shifting away from sides — though this is secondhand [T4] and should be treated as medium-quality). If consensus is wrong, it is wrong by pricing a narrative break where the data show only an execution stumble.

The one thing to watch

The variable to watch is not Q3 comps — it is estimate-revision breadth in the 30-60 days after the Oct 22 print. The entire bear case is currently carried by revisions momentum (FY26: 2 up / 11 down; FY27: 2 up / 13 down in the last 30 days). If FY2027 EPS estimates hold near $13.77 while the stock stays ~30% below its 52w high, this is provably multiple compression on an intact earnings base, and ~17x is a floor; if revisions keep cascading after Q3, the market was correctly front-running a franchise-model repricing and 17x is a value trap. The Q2 comps number itself is almost noise by comparison.

Key evidence (9)
  • FY2025: revenue $26.885B (+3.7%), diluted EPS $11.95 (+4.9%), operating margin 46.1% — best of the 2021-25 series [SEC XBRL, T1]
  • Q2 2026 (reported Aug 4, 2026): adj EPS $3.38 beat ~$3.32, but US comps +0.8% missed ~+1.06% consensus; global comps +1.3% vs +3.8% a year earlier; management admitted US value push 'did not resonate' [Reuters T2; MCD release]
  • Sept 23, 2026 investor day: $8.5B franchisee support through 2036 (~$5B by 2030, rent relief + capital); stock fell up to 6.5% on the day; management warned industry traffic in key markets could stay flat [Reuters/Bloomberg T2]
  • 2030 targets: ~10,000 net new units by 2027, ~2% systemwide sales growth from unit expansion, operating margin low-to-mid 50s%, FCF conversion mid-to-high 80s%; no standalone EPS growth target disclosed [Investor Day release; CNBC T3]
  • Forward P/E ~17.0-17.9x as of Oct 1-8, 2026, vs ~27.6x in 2023 and far higher historically [Yahoo/StockAnalysis/Eulerpool — T4 aggregator data; direction reliable, exact figures weakly sourced]
  • Estimate revisions, last 30 days: FY2026 EPS 2 up / 11 down; FY2027 2 up / 13 down [businessquant/Yahoo T4]
  • Price/quant: -20.1% 1y, -23.5% 6m, 30.5% below 52w high, 2.6% above 52w low, max drawdown -32.3%, 20d vol at 90th percentile; 1y correlation to SPY ~0.01 (fully idiosyncratic); peers: YUM -2.5%, QSR +5.1%, CMG -20.2% 1y [computed from daily prices]
  • GLP-1: no evidence of demand collapse; 2026 National Restaurant Association survey cited in coverage found GLP-1 users purchase restaurant food 7.6x/week vs 5.1x for non-users, with mix shifting from sides/snacks [ABC News T4 — secondhand, medium quality]; MCD adapting menus with protein/portion flexibility [Reuters/Bloomberg T2]
  • Next earnings ~Oct 22, 2026; consensus ~$7.33B revenue / ~$3.40 EPS [Reuters T2]
Catalysts and risks

Catalysts

  • Q3 2026 earnings ~Oct 22, 2026 (consensus ~$7.33B rev / ~$3.40 EPS) — US comps and value-execution commentary are the swing factors
  • Estimate-revision direction in the 30-60 days following the print
  • Any update on deployment pace/terms of the $8.5B franchisee support ($5B by 2030)
  • US traffic/value-menu data points (monthly industry traffic, competing value launches from QSR/Wendy's)
  • GLP-1 adoption data and any quantified restaurant-demand studies
  • Commodity (beef) cost trajectory and any China/geopolitical developments — unverified this round

Risks

  • Q3 US comps miss again, confirming the value platform isn't working and triggering another estimate-cut wave
  • The $8.5B proves to be the first tranche of a larger franchisee bailout, compressing royalty/rent economics structurally
  • Consumer weakness is genuinely industry-wide (CMG also -20%), so execution fixes don't restore traffic
  • GLP-1 mix shift (fewer sides/snacks per visit) erodes check size even if traffic holds
  • Beef/commodity inflation squeezes franchisee margins further, worsening the franchisee-health problem
  • Historical P/E comparisons rest on T4 aggregator data — the 'decade-low multiple' claim is directionally sound but imprecisely sourced
What to watch
  • Estimate-revision breadth (up vs down counts) for FY26/FY27 in the 30-60 days post-Q3 — the single highest-signal variable
  • Q3 US comparable sales vs the ~+1% bar and management's value-execution commentary
  • Any disclosure on franchisee economics: rent relief uptake, franchisee cash-flow margins, unit closures
  • Peer US comps (YUM/Taco Bell, QSR/Burger King, Wendy's) to separate MCD-specific execution from industry demand
  • GLP-1 penetration data and menu-mix evidence (attach rates on sides/beverages)
  • Beef and labor cost trends into 2027
  • Buyback pace — whether the company is defending the multiple with repurchases at these levels
Market snapshot when the call was made 2026-10-08

Price

Return 1w+2.2%
Return 1m-6.5%
Return 3m-13.7%
Return 6m-23.5%
Return 1y-20.1%
From 52-week high-30.5%
Realized vol, 20d24.2%
SPY 3m / 1y+2.5% / +15.7%
QQQ 3m / 1y+3.0% / +23.7%

Technicals

MCD technicals as of 2026-10-08: last close $236.90; 20d SMA 240.68 (bearish); 50d SMA 256.31; 12d EMA 236.06; 26d EMA 243.21; RSI 14 33.0 (balanced); 20d vol 24.0%; volume x1.7 vs 20d avg

Verifier notes REVISE · opinion revised once

Unsupported claims

  • Bull case: 'a franchise model that grew EPS ~8% in FY2025' — the SEC XBRL evidence shows FY2025 diluted EPS of $11.95 vs $11.39 in FY2024, i.e. +4.9% (which the opinion itself states correctly in the answer and key_evidence). The ~8% figure in the evidence applies to FY2026 consensus ($12.89, +7.9% off $11.95), not to FY2025 actuals. This overstates trailing growth by ~60% in the core bull-case sentence.

Internal inconsistencies

  • bull_case asserts FY2025 EPS growth of ~8% while the answer, thesis, and key_evidence all state FY2025 EPS grew 4.9% — the opinion contradicts itself on a basic fact.
  • why_market_may_be_wrong lists 'systemwide sales +5%, loyalty users +13% to ~220M' inside a sentence framed as FY2025 results ('FY2025 revenue +3.7%, EPS +4.9%, record operating margin, systemwide sales +5%...'), but the evidence shows systemwide sales +5% (~$37B) and loyalty +13% to ~220M are Q2 2026 quarterly figures, not FY2025 annuals. Minor scoping error, but it misattributes the data period.

Corrections applied

  • In bull_case, change 'grew EPS ~8% in FY2025' to either 'grew EPS ~5% in FY2025 with consensus implying ~8% growth in FY2026' or 'is expected to grow EPS ~8% in FY2026 per consensus ($12.89 vs $11.95)'.
  • In why_market_may_be_wrong, rescope the trailing-data sentence, e.g.: 'FY2025 revenue +3.7%, EPS +4.9%, record operating margin; and Q2 2026 systemwide sales +5% with loyalty users +13% to ~220M.'
Sources (22 · T1 = primary filings)

Earlier and later calls on MCD

Want a fresh look at MCD, or another name?

Queue a new deep-research run. Published to the feed when done.

Automated research opinion, published as-is on Oct 9, 2026. Not personalised advice. Figures use end-of-day closes.